Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Medical Research Group of Central Florida
mi
from
Sanford, FL
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Medical Research Group of Central Florida
mi
from
Sanford, FL
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
University of South Florida
mi
from
Tampa, FL
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Institute for Behavioral Medicine
mi
from
Smyrna, GA
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Institute for Behavioral Medicine
mi
from
Smyrna, GA
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Capstone Clinical Research
mi
from
Libertyville, IL
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Capstone Clinical Research
mi
from
Libertyville, IL
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Baber Research Group
mi
from
Naperville, IL
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Baber Research Group
mi
from
Naperville, IL
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
University of Kentucky
mi
from
Lexington, KY
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Neuroscientific Insights
mi
from
Rockville, MD
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Neuroscientific Insights
mi
from
Rockville, MD
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Neurobehaviorial Medicine Group, PLLC
mi
from
Bloomfield Hills, MI
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Neurobehaviorial Medicine Group, PLLC
mi
from
Bloomfield Hills, MI
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Children's Specialized Hospital
mi
from
Toms River, NJ
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Children's Specialized Hospital
mi
from
Toms River, NJ
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Montefiore Medical Center PRIME
mi
from
Bronx, NY
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Montefiore Medical Center PRIME
mi
from
Bronx, NY
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Finger Lakes Clinical Research
mi
from
Rochester, NY
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Finger Lakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Richmond Behavioral Associates
mi
from
Staten Island, NY
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Richmond Behavioral Associates
mi
from
Staten Island, NY
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Chapel Hill Neurology
mi
from
Chapel Hill, NC
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Chapel Hill Neurology
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Ohio State University Nisonger Center
mi
from
Columbus, OH
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Ohio State University Nisonger Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Cyn3rgy Research & Development
mi
from
Gresham, OR
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Cyn3rgy Research & Development
mi
from
Gresham, OR
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Suburban Research Associates
mi
from
Media, PA
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Suburban Research Associates
mi
from
Media, PA
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Segal Institute for Clinical Research
mi
from
Charleston, SC
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Segal Institute for Clinical Research
mi
from
Charleston, SC
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Family Psychiatry of the Woodlands
mi
from
The Woodlands, TX
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Family Psychiatry of the Woodlands
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Ericksen Research And Development
mi
from
Clinton, UT
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Ericksen Research And Development
mi
from
Clinton, UT
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
CRI Lifetree
mi
from
Salt Lake City, UT
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
CRI Lifetree
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
University of Virginia
mi
from
Charlottesville, VA
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
NeuroScience, Inc.
mi
from
Herndon, VA
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Carilion Clinic
mi
from
Roanake, VA
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Carilion Clinic
mi
from
Roanake, VA
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Pacific Institute of Medical Sciences
mi
from
Bothell, WA
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Pacific Institute of Medical Sciences
mi
from
Bothell, WA
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
University of California, San Francisco Medical Center
mi
from
San Francisco, CA
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
University of California, San Francisco Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
Kennedy Krieger Institute
mi
from
Baltimore, MD
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME)
Targeted Self-Management for Epilepsy and Serious Mental Illness
Status: Enrolling
Updated:  1/27/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME)
Targeted Self-Management for Epilepsy and Serious Mental Illness
Status: Enrolling
Updated: 1/27/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Framingham, MA
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Framingham, MA
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
New York, NY
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Tullahoma, TN
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Tullahoma, TN
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Tucson, AZ
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Garden Grove, CA
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Newport Beach, CA
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Santa Ana, CA
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Tustin, CA
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Tustin, CA
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Coral Gables, FL
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Ocala, FL
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Palm Beach Gardens, FL
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Evansville, IN
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Springfield, MA
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Springfield, MA
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
St. Louis, MO
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated:  1/28/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Status: Enrolling
Updated: 1/28/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials